Nikko Asset Management Americas’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
WP
PHS
Nikko Asset Management Americas's EDIT Position: Q4 2022 in Review
Nikko Asset Management Americas sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 355,836 shares — an estimated $4.36M sold.
Nikko Asset Management Americas first reported a position in EDIT in Q3 2018 and held it in 17 quarters. The position peaked at $308M in Q4 2020. 249 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.
- Nikko Asset Management Americas reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
- Nikko Asset Management Americas sold 355,836 Editas Medicine shares in Q4 2022, an estimated $4.36M.
- Nikko Asset Management Americas first reported a position in Editas Medicine in Q3 2018 and held it in 17 quarters.
- Nikko Asset Management Americas's Editas Medicine position peaked at $308M in Q4 2020.
- 249 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.
Based on Nikko Asset Management Americas's 13F filing for Q4 2022, filed 13 Feb 2023.